erlotinib hydrochloride has been researched along with molybdenum disulfide in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (molybdenum disulfide) | Trials (molybdenum disulfide) | Recent Studies (post-2010) (molybdenum disulfide) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 624 | 0 | 597 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, L; Li, B; Liu, J; Lu, Y; Wang, J; Zhang, C; Zhang, D; Zheng, J | 1 |
1 other study(ies) available for erlotinib hydrochloride and molybdenum disulfide
| Article | Year |
|---|---|
Functionalized MoS
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Disulfides; Drug Carriers; Drug Liberation; Erlotinib Hydrochloride; Female; Humans; Hyaluronic Acid; Hydrogen-Ion Concentration; Hyperthermia, Induced; Infrared Rays; Mice, Inbred BALB C; Mice, Nude; Molybdenum; Nanocomposites; Phototherapy | 2019 |